Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Early-Stage Breast Carcinoma|Hormone Receptor Positive Tumor
Interventions: DRUG: Tamoxifen or Aromatase Inhibitor or Aromatase Inhibitor + goserelin|DRUG: Palbociclib
Sponsor: Thomas Hatschek